NDC11 82260046605
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 82260-0466-05 | 82260-0466 |
| 82260-0466-5 | 82260-0466 |
| 82260-466-05 | 82260-466 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Besivance | BESIFLOXACIN | Bausch & Lomb Americas Inc. | ff971287-5610-4f15-8392-fc974e6ff646 | 2026-01-12 | Warnings, Adverse reactions | 82260-466-05 82260-466 82260046605 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.